Dictionary for Clinical Trials
by: Simon Day
en | Wiley

047005817X 9780470058176 9780470319161

Dictionary for Clinical Trials
By Simon Day

Publisher: Wiley
Number Of Pages: 262
Publication Date: 2007-06-11
ISBN-10 / ASIN: 047005817X
ISBN-13 / EAN: 9780470058176

Product Description:

As a result of the expansion in the area of pharmaceutical medicine there is an ever-increasing need for educational resources. The Dictionary of Clinical Trials, Second Edition comprehensively explains the 3000 words and short phrases commonly used when designing, running, analysing and reporting clinical trials.

This book is a quick, pocket reference tool to understand the common and less well-used terms within the discipline of clinical trials, and provides an alternative to the textbooks available. Terms are heavily cross-referenced, which helps the reader to understand how terms fit into the broad picture of clinical trials.

Wide ranging, brief, pragmatic explanations of clinical trial terminology
Scope includes medical, statistical, epidemiological, ethical, regulatory and data management terminology
Thoroughly revised and expanded - increase of 280 terms from First Edition, reference to Cochrane included
From the reviews of the First Edition:

"This invaluable text explains the majority of clinical trial terms, in alphabetical order, that are likely to be found in clinical trial protocols, reports, regulatory guidelines, and published manuscripts… Fully comprehensive - provides definitions of clinical trial terms in one complete volume… Includes extensive use of graphs throughout." LA DOC STI

"…covers a range of subject matter, with emphasis on medical, statistical, epidemiological and ethical terms… a useful adjunct to standard clinical trial texts… a reference source to keep within easy reach." TALANTA

The Dictionary of Clinical Trials, Second Edition is a ‘must-have’ for all pharmaceutical companies who conduct a lot of clinical trials, in all or one therapeutic area. The book is also of interest for public health and health science workers, and for contract research organisations and departments of medicine, where medics are involved with clinical trials.

Summary: Skimpy, minimalist definitions and overpriced
Rating: 1

This is the sort of book that one might expect to receive as a "freebee" from a drug company representative. For $…, it is very overpriced. Considering that for around the same amount of money, one can buy a very thorough medical dictionary, this "book" falls short. Save your money and apply it towards a "real" text.

Summary: I use this every day !
Rating: 5

As a newcomer to the pharmaceutical industry, this book has helped me to understand the jargon that is everyday language for clinical research associates. Explanations are presented simply

Please Login or Register to read the rest of this content.
Random Posts

• Cardiac Perfusion and Pumping Engineering (Clinically-Oriented Biomedical Engineering) (Clinically-Oriented Biomedical Engineering) (0)
• Inhalation Aerosols (Lung Biology in Health and Disease) (0)
• Management of the Addicted Patient in Primary Care (0)
• Drugs of Abuse: Body Fluid Testing (Forensic Science and Medicine) (0)
• Cell-Penetrating Peptides: Processes and Applications (0)
• On Deep History and the Brain (0)

Handbook of Pharmaceutical Manufacturing Formulations: Liquid Products (Volume 3 of 6)
by: Sarfaraz K. Niazi
en | Informa HealthCare

0849317487 9780849317484 9781420048452

Handbook of Pharmaceutical Manufacturing Formulations: Liquid Products (Volume 3 of 6)
By Sarfaraz K. Niazi

Publisher: Informa HealthCare
Number Of Pages: 320
Publication Date: 2004-04-26
ISBN-10 / ASIN: 0849317487
ISBN-13 / EAN: 9780849317484

Product Description:

The third volume in the six-volume Handbook of Pharmaceutical Manufacturing Formulations, this book covers liquid drugs, which include formulations of non-sterile drugs administered by any route in the form of solutions (monomeric and multimeric), suspensions (powder and liquid), drops, extracts, elixirs, tinctures, paints, sprays, colloidons, emulsions, aerosols, and other fluid preparations from publicly available but widely dispersed information from FDA New Drug Applications (NDA), patent applications, and other sources of generic and proprietary formulations. Each entry begins with a fully validated scaleable manufacturing formula and a summary of manufacturing process. The book provides a detailed discussion on the difficulties encountered in formulating and manufacturing liquid drugs, the common elements of formulation. The section on regulatory and manufacturing guidance deals with the topics of changes to approved NDAs and aNDAs, post-approval changes to semisolid drugs, global manufacturing practices and guidelines, compliance program guidance manual for FDA staff covering drug manufacturing inspections program, waiver of in vivo bioavailability studies for immediate release solid drugs based on a biopharmaceutics classification, in addition to providing quick tips on resolving the common problems in formulating uncompressed drugs.

Please Login or Register to read the rest of this content.
Random Posts

• Bioinformatics: Experiments, Tools, Databases, and Algorithms (0)
• Pre-eclampsia: Etiology and Clinical Practice (0)
• Musculoskeletal Fatigue and Stress Fractures (CRC Series in Exercise Physiology) (0)
• Biological Invasions: Theory and Practice (Oxford Series in Ecology and Evolution) (0)
• Butterfly (See How They Grow) (0)
• Genetics Databases (Biological Techniques Series) (0)

Pharmaceutical Perspectives of Cancer Therapeutics
by: Yi Lu, Ram I. Mahato

Pharmaceutical Perspectives of Cancer Therapeutics
By Yi Lu, Ram I. Mahato

Publisher: Springer
Number Of Pages: 602
Publication Date: 2009-07-21
ISBN-10 / ASIN: 1441901302
ISBN-13 / EAN: 9781441901309

Product Description:

The goal of our efforts in compiling Pharmaceutical Perspectives of Cancer Therapeutic is to produce a comprehensive yet easy-to-follow review of the principles and current approaches in this ever-growing field. With today’s broad research perspective and technology expertise, the knowledge in the field of cancer research and drug development has become a challenge not only for students who are eager to learn, but also for seasoned professionals who are willing to update. The complexity of cancer demands a comprehensive and integrated understanding from both cancer biology and pharmaceuticaldosage forms and drug delivery in order to warrant a successful therapeutic regimen. However, no book to date combinestogether these two aspects, namely the cancer research and the drug design and delivery from an integrated perspective of cancer treatment. Hence, a book that merges the knowledge from these two aspects is greatly desired.

For the purpose of bridging basic research and clinical application, pharmaceutical drug development processes and regulatory issues, drug design and delivery, laboratory and translational experimentation, marketing and postmarketing surveillance,we have invited international experts with a multi-disciplinary background, including scientists and clinicians from both academia and industries in theirrespective fields to contribute to this book. We intend to convey both an introductory understanding and the latest development in the field so that this book can be useful for both novice students and practicing scientists. With a comprehensive and integrated view of cancer therapeutics, we hope that this book will stimulate a deeper understanding and promote interaction in this integrated field for people with diverse expertise and backgrounds who are working on cancer therapeutics.

We have organized this book to cover a wide variety of topics including strategies to suppress tumor angiogenesis and metastasis, overcome multi-drug resistance in cancer, target telomerase and apoptosis pathways;therapeutic approaches to employ monoclonal antibody and cancer vaccines;introduction of new concepts such as cancer stem cells and new technologies such as nanobiotechnology, RNA interference, microRNA, and cancer cell gene profiling. The use of synthetic carriers, such as lipids, polymers and peptides for delivery and targeting of small molecules, proteins and nucleic acids to cancer cells or specific organs in vivo, as well as targeted delivery of macromolecular drugs to cancer cells, are described in detail. In addition, the utilization of imaging in cancer therapeutics, development and utilization of HIF-1 knockout animal models in cancer study, as well as the principles of developing anticancer drugs and designing clinical trials, are also discussed. In summary, this book provides an in-depth review of various aspects of anticancer strategies and drug delivery approaches from different perspectives, including detailed discussion of several clinical trial cases. The book has a wider and more involved focus on cancer therapy with a good balance on diversity. It integrates cancer therapy approaches (both biological- and small compound molecule-based therapy) with drug delivery. By reading this book, not only bench scientists can have an insight for what physicians desire for their clinical use towards cancer treatment, but also physicians will better understand how the approach and drug are developed and therefore will apply the drug more efficiently and accurately in patients. Moreover, this book summarizes current progress and state-of-the-art of cancer therapeutics, while focusing on the novel ideas that are being explored to overcome the existing challenges. We hope that this book will be served as both a refresher and ready-reference, as well as an educational tool, to both new entrants and seasoned researchers.

Please Login or Register to read the rest of this content.
Random Posts

• Clarke’s Isolation and Identification of Drugs (0)
• Community Mental Health Teams (Oxford Medical Publications) (0)
• Handbook of Obesity Treatment (0)
• Innervation of the Mammalian Esophagus (Advances in Anatomy, Embryology and Cell Biology) (0)
• Science Readers - Life Science: Inside Ecosystems and Biomes (Science Readers: Life Science) (0)
• Eye Movement Integration Therapy: The Comprehensive Clinical Guide (0)

Evidence-based Pharmacy
by: Phil Wiffen
en | Radcliffe Publishing

1857753844 9781857753844 9781417519958

Evidence-based Pharmacy
By Phil Wiffen

Publisher: Radcliffe Publishing
Number Of Pages: 168
Publication Date: 2001-06-29
ISBN-10 / ASIN: 1857753844
ISBN-13 / EAN: 9781857753844

Product Description:

This clear and concise book shows the reader how to answer basic questions such as: / does this treatment work? / What unwanted effects might a treatment give? / What is the best treatment for a given condition? / How can I extract useful information? The book explains the need for evidence-based medicine (EBM) and outlines the best ways to analyse and evaluate published information. It guides the reader in identifying the right evidence and assessing its value in day-to-day practice. The book includes a section on making best use of the Internet, shows the many uses of evidence in pharmacy and gives specific examples to illustrate key points. Useful appendices provide information on website addresses, journals and other publications from the Department of Essential Drugs and Medicines Policy. It is essential reading for pharmacists in hospitals, in the pharmaceutical industry and in the community, and for students of pharmacy.

Please Login or Register to read the rest of this content.
Random Posts

• Movement Disorders: 100 Instructive Cases (0)
• Transgenesis and the Management of Vector-Borne Disease (Advances in Experimental Medicine and Biology) (0)
• Obesity and Diabetes, 2nd edition (Practical Diabetes) (0)
• Waterbug Book: A Guide to the Freshwater Macroinvertebrates of Temperate Australia (0)
• Fixing Health Systems (In-Focus) (0)
• Guidance on Allocating and Targeting Pandemic Influenza Vaccine (2008) (0)